Correlation Between West Pharmaceutical and Lucid Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both West Pharmaceutical and Lucid Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining West Pharmaceutical and Lucid Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between West Pharmaceutical Services and Lucid Diagnostics, you can compare the effects of market volatilities on West Pharmaceutical and Lucid Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in West Pharmaceutical with a short position of Lucid Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of West Pharmaceutical and Lucid Diagnostics.

Diversification Opportunities for West Pharmaceutical and Lucid Diagnostics

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between West and Lucid is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding West Pharmaceutical Services and Lucid Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lucid Diagnostics and West Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on West Pharmaceutical Services are associated (or correlated) with Lucid Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lucid Diagnostics has no effect on the direction of West Pharmaceutical i.e., West Pharmaceutical and Lucid Diagnostics go up and down completely randomly.

Pair Corralation between West Pharmaceutical and Lucid Diagnostics

Considering the 90-day investment horizon West Pharmaceutical Services is expected to generate 0.7 times more return on investment than Lucid Diagnostics. However, West Pharmaceutical Services is 1.43 times less risky than Lucid Diagnostics. It trades about 0.06 of its potential returns per unit of risk. Lucid Diagnostics is currently generating about -0.07 per unit of risk. If you would invest  31,457  in West Pharmaceutical Services on September 5, 2024 and sell it today you would earn a total of  732.00  from holding West Pharmaceutical Services or generate 2.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

West Pharmaceutical Services  vs.  Lucid Diagnostics

 Performance 
       Timeline  
West Pharmaceutical 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in West Pharmaceutical Services are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, West Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Lucid Diagnostics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lucid Diagnostics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, Lucid Diagnostics exhibited solid returns over the last few months and may actually be approaching a breakup point.

West Pharmaceutical and Lucid Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with West Pharmaceutical and Lucid Diagnostics

The main advantage of trading using opposite West Pharmaceutical and Lucid Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if West Pharmaceutical position performs unexpectedly, Lucid Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lucid Diagnostics will offset losses from the drop in Lucid Diagnostics' long position.
The idea behind West Pharmaceutical Services and Lucid Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.